Marcio Mancini
Dr. Marcio Mancini is an esteemed endocrinologist and the coordinator of the Department of Obesity and Metabolic Syndrome at the Brazilian Society of Diabetes (SBD). He is recognized for his expertise in diabetes management and has publicly advised against the use of manipulated semaglutide, emphasizing the potential risks associated with such products, including inaccurate dosages and severe side effects.
Not in the pool (under ¢1).
Recent news mentions
Marcio Mancini is the coordinator of the Department of Pharmacology at the Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso).
Muito antes de Wegovy e Mounjaro: conheça remédios mais baratos usados para tratar obesidade
Liechtenstein· 2025-10-11
Marcio Mancini, director of the Brazilian Association for Studies of Obesity and Metabolic Syndrome, stated that purchasing medication from another country without guidance poses many risks.
Adelgazante paraguayo es vendido de forma ilegal en Brasil, según investigación periodística - Nacionales
Paraguay· 2025-07-06Marcio Mancini explains that studies showed that when the medication is interrupted, weight returns.
nova diretriz orienta tratamento com remédios como Ozempic, Mounjaro e Wegovy; veja para quem
Brazil· 2025-05-30
Marcio Mancini is the coordinator of the Department of Obesity and Metabolic Syndrome at the SBD and advises against the use of manipulated semaglutida.
Entidades médicas alertam para riscos de usar versões manipuladas de Ozempic, Wegovy e MounjaroLiechtenstein· 2025-02-16
